Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02299479 · ClinicalTrials.gov registry record · NA

Adjusting Insulin Delivery to Activity

A NA study of Diabetes and Nocturnal Hypoglycemia, sponsored by Boston Children's Hospital.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT02299479 is a NA study of Diabetes and Nocturnal Hypoglycemia that has completed, run by Boston Children's Hospital. The registered enrollment target is 20 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02299479, a NA study of Diabetes and Nocturnal Hypoglycemia, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Increased daytime activity in children and adolescents with type I diabetes is known to be associated with overnight hypoglycemia. We therefore wish to perform a prospective clinical study to assess the feasibility of using activity monitor data to adjust insulin pump basal rates and see whether we can help prevent overnight hypoglycemia or decrease related interventions following high activity days. We plan to carry this out by enrolling 20 subjects (10 subjects 1 to \<7 years old and 10 subjects 7 to 17 years old) with type 1 diabetes managed on insulin pump therapy and having them wear activity monitors and CGMs for up to 3 months. After an initial two-week period to establish activity baselines, we will recommend nighttime basal insulin rate adjustments based on activity monitor, CGM and insulin pump data.

Interventions

  • DEVICE Dexcom G4 Platinum CGM
  • DEVICE Activity monitor

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2015-07
Est. Completion 2017-06-27
Phase NA

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT02299479

The ClinicalTrials.gov registry entry for NCT02299479 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Dexcom G4 Platinum CGM is the first listed.

NCT02299479 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02299479 about?

NCT02299479 is a clinical study titled "Adjusting Insulin Delivery to Activity". Increased daytime activity in children and adolescents with type I diabetes is known to be associated with overnight hypoglycemia. We therefore wish to perform a prospective clinical study to assess the feasibility of using activity monitor data to adjust insulin pump basal rates and see whether we ...

What is the current status of trial NCT02299479?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2015-07. Estimated completion is 2017-06-27.

What conditions does trial NCT02299479 study?

This clinical trial studies the following conditions: Diabetes, Nocturnal Hypoglycemia.

What interventions are being tested in trial NCT02299479?

The interventions under investigation include: Dexcom G4 Platinum CGM (DEVICE), Activity monitor (DEVICE).

Who is sponsoring clinical trial NCT02299479?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02299479 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.